News

July 9, 2012 — Miracor Medical Systems GmbH announced that the first three ST segment elevation myocardial infarction (STEMI) patients enrolled in its “Prepare RAMSES” ...

July 9, 2012 — Cardionovum GmbH announced it has initiated in vivo testing of its second drug-eluting balloon (DEB) Restore. The company is currently marketing a line...

June 21, 2012 — TriReme Medical Inc. (TMI) announced today that it has received U.S. Food and Drug Administration (FDA) clearance for an expanded matrix of sizes for its Chocolate percutaneous...

June 13, 2012 — Physicians presented at EuroPCR 2012 the results of two multicenter, randomized controlled trials, the BELLO and PACIFIER studies, each one showing statistically significant...

May 30, 2012— Boston Scientific Corp. announces the U.S. Food and Drug Administration has cleared an expanded use indication for the CRE Wireguided Balloon Dilator for endoscopic dilation of the...

May 23, 2012 - TriReme Medical Inc. announced approval by the U.S. Food and Drug Administration (FDA) of the Glider PTCA Catheter, indicated for treating the stenotic portion of coronary arteries...

May 4, 2012 - Angioslide Ltd., a provider of embolic capture angioplasty solutions, announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its new 3x100 mm...

May 4, 2012 - A new balloon catheter system could advance the endovascular approach to treating obstructed...

April 24, 2012 - Boston Scientific Corp. announces CE mark and European market launch of the Emerge PTCA Dilatation Catheter. The Emerge catheter is a next-generation pre-dilatation balloon...

April 17, 2012 –– Expanding its commitment to developing innovative treatments for cardiovascular disease and the evidence to support their adoption, Medtronic announced the start of the Medtronic...

March 20, 2012 - MarBlue Medical announced the global product launch of its CE-marked drug-eluting balloon (DEB) Protege as well as its CoCr stent on DEB Pioneer. The full market launch of the new...

January 25, 2012 — Physicians at University Hospitals (UH) Case Medical Center enrolled their first patient in LEVANT 2, a global, multicenter, randomized clinical trial evaluating the safety and...

January 6, 2012 - C. R. Bard recently announced it acquired drug-eluting balloon maker Lutonix Inc. for $225 million. Following successful approval of a U.S. Food and Drug Administration (FDA) pre...

December 28, 2011 – Good Samaritan Hospital in Los Angeles is participating in the Levant 2 clinical trial to investigate a potential new treatment option for people with peripheral artery disease...

December 15, 2011 — Neovasc Inc. announced it has received the CE mark designation for its Reducer product for the treatment of refractory angina. CE marking confirms the Reducer conforms to...

December 13, 2011 – Boston Scientific announced the U.S. launch of its Charger PTA Balloon Catheter, a 0.035-inch percutaneous transluminal angioplasty (PTA) balloon catheter designed for a wide...

November 15, 2011 – Results from the PROFI study indicate that the use of a proximal balloon occlusion in carotid artery stenting lead to fewer cerebral ischemic lesions...

November 14, 2011 – Boston Scientific welcomed positive outcomes from the COBRA clinical trial, which evaluated post-dilation of nitinol stents using CryoPlasty therapy with the PolarCath...

November 14, 2011 – Medrad Inc. announced that five-year data from the THUNDER trial [1] demonstrated a 59 percent relative reduction in target lesion revascularization (TLR) rates in popliteal...

November 14, 2011 — A clinical trial of patients with restenosis in drug-eluting stents (DES) in native coronary arteries found treatment with paclitaxel-coated balloon angioplasty demonstrated...